ÂÜÀòÂÒÂ×

Dr. Steven Krill has over 30 years of pharmaceutical development experience. Prior to joining Epalex, he was Executive Vice President and Chief Scientific Officer at Eagle Pharmaceuticals. He has also held positions as Vice President of Scientific Affairs at Teva Pharmaceuticals, Vice President of Pharmaceutical R&D at Boehringer Ingelheim, Vice President of Technology Development at Lipocine Inc., Associate Director of Pharmaceutical Development at Novartis Pharmaceuticals Corporation, and Pharmaceutics Center Head at Abbott Laboratories. Dr. Krill is an author of over 30 peer-reviewed publications and an inventor on over 10 patents/patent applications, He holds a BS degree in Pharmacy from the University of Cincinnati, an MS degree in Physical Pharmacy from the University of Cincinnati, and a Ph.D. degree in Pharmaceutics from the University of Utah, where he studied under Distinguished Professor William I. Higuchi, Ph.D.